BioAlert Solutions Inc.

BioAlert Solutions Inc. specializes in automated Legionella monitoring, providing essential water quality management solutions for industries reliant on cooling systems through its innovative BioAlert technology. BioAlert Solutions Inc. was founded in 2014 by CEO President Etienne Lemieux and Vice-President Dominic Carrier and is based in Sherbrooke, Canada.

The company focuses on providing continuous on-site monitoring for Legionella, a serious public health concern. The company has executed one deal to date, with its most recent funding occurring on March 25, 2025, when it raised USD 2. 5 mn in Seed funding. This round was co-led by Cycle Capital Management and GreenSky Ventures, with participation from Fondaction CSN and Spring Impact Capital.

The company was formed by industry experts with significant experience in water quality management. BioAlert Solutions Inc. specializes in continuous on-site Legionella monitoring through its core product, BioAlert. This innovative solution is designed to operate without human intervention, being directly installed at cooling system sites to automate the sampling and testing processes.

The system tests water samples and provides results in less than four hours, facilitating daily analysis of Legionella levels. By empowering clients to monitor their systems remotely through a controlled platform, BioAlert addresses critical public health concerns for industries reliant on cooling systems, such as healthcare, hospitality, and manufacturing. The company serves a diverse clientele across North America, with a particular focus on urban centers where cooling systems are prevalent. BioAlert Solutions Inc.

engages in a transactional model primarily based on subscriptions for its monitoring services. Clients enter into service agreements allowing them to access BioAlert's continuous monitoring capabilities, which include automated testing and comprehensive reporting. These arrangements enable efficient management of Legionella risks, enhancing safety standards within the client's facilities. The revenue structure is driven by recurring subscription fees, ensuring a steady income stream as customers rely on BioAlert's technology for ongoing compliance and safety assurance.

Specific pricing plans for these services have not been disclosed; however, the core offerings revolve around the BioAlert monitoring system, ensuring that clients receive timely and accurate results for effective water management. In March 2025, BioAlert Solutions Inc. raised USD 2. 5 mn in Seed funding, which will be utilized to enhance the scope and accessibility of its automated water quality monitoring technology.

The company plans to design and launch new products aimed at further improving Legionella detection capabilities, with specific details about future releases expected in the coming year. Additionally, BioAlert aims to expand into new geographic regions, particularly targeting urban centers in the United States and Europe by 2026.